The authors declare no conflict of interest.
Letter to the Letter
Article first published online: 17 OCT 2012
DOI: 10.1002/ajmg.b.32105
Copyright © 2012 Wiley Periodicals, Inc.
Issue
1552-485X/asset/cover.gif?v=1&s=1311dc9f78d73ed3cc2334be9fec1778ee8bc608)
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Volume 159B, Issue 8, pages 1006–1008, December 2012
Additional Information
How to Cite
Gupta, M., Jain, S., Moily, N. S., Kaur, H., Jajodia, A., Purushottam, M. and Kukreti, R. (2012), Genetic studies indicate a potential target 5-HTR3B for Drug Therapy in Schizophrenia Patients. Am. J. Med. Genet., 159B: 1006–1008. doi: 10.1002/ajmg.b.32105
- †
- ‡
How to Cite this Article: Gupta M, Jain S, Moily NS, Kaur H, Jajodia A, Purushottam M, Kukreti R. 2012. Genetic Studies Indicate a Potential Target 5-HTR3B for Drug Therapy in Schizophrenia Patients. Am J Med Genet Part B 159B:1006–1008.
Publication History
- Issue published online: 8 NOV 2012
- Article first published online: 17 OCT 2012
- Manuscript Accepted: 26 SEP 2012
- Manuscript Received: 27 AUG 2012
Funded by
- Department of Biotechnology (DBT)
- Council of Scientific and Industrial Research (CSIR)
- Abstract
- Article
- References
- Supporting Information
- Cited By
Additional Supporting Information may be found in the online version of this article.
| Filename | Format | Size | Description |
|---|---|---|---|
| ajmg_32105_sm_SupplData.doc | 41K | Supplementary Data | |
| ajmg_32105_sm_SupplTab1.doc | 142K | Supplementary Table S1 | |
| ajmg_32105_sm_SupplTab2.doc | 133K | Supplementary Table S2 |
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

1552-485X/asset/olbannerleft.gif?v=1&s=0e43f7e039a24ecded43bfd7a5ca0adda740e12f)
1552-485X/asset/olbannerright.gif?v=1&s=b0c982f852f9ce2872fa6ab21687106020e0e7d3)